<!DOCTYPE html>
<html lang="en" dir="ltr">
    <head>
        <meta charset="utf-8" name="viewport" content="width=device-width, initial-scale=1.0">
        <title> Medications </title>
        <link rel="shortcut icon" href="../../images/Calculator.ico">

        <!-- External Scripts -->
        <script src="https://ajax.googleapis.com/ajax/libs/jquery/2.1.3/jquery.min.js"></script>

        <!-- Local Scripts -->

        <script src="../../global/global.js"></script>
        <script src="Medications.js"></script>


        <!-- CSS -->
        <link rel="stylesheet" href="../../global/global.css"/>
        <link rel="stylesheet" href="Medications.css"/>



        <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.3.1/css/all.css" integrity="sha384-mzrmE5qonljUremFsqc01SB46JvROS7bZs3IO2EmfFsd15uHvIt+Y8vEf7N7fWAU" crossorigin="anonymous">

    </head>

    <body>
        <header class="header-container">

            <div onclick="openNav()">
                <i class="fas fa-bars fa-2x"></i>
            </div>
            <div class="header-box logo">
                <i class="fa fa-medkit fa-2x" aria-hidden="true"></i>
            </div>
            &nbsp
            <div class="header-title">
                Medications
            </div>

        </header>
        <main class="main-container">
            <div id="mySidenav" class="sidenav">
                <a href="javascript:void(0)" class="closebtn" onclick="closeNav()">&times;</a>
                <a href="../../index.html">Opioid Converter</a>
                <a href="../../Pages/FluidConvert/fluidsconvert.html">Fluid Calculator</a>
                <a href="../../Pages/FluidGuide/FluidGuide.html">Fluid Guide</a>
                <a href="../../Pages/Medications/Medications.html">Medications</a>
            </div>
            <div id="mainform">
                <h1> Common Medication Dosages </h1>
                <input id="myInput" type="text" placeholder="Search..">
                <div style="overflow-x:auto;">
                <table>
                    <thead>
                        <tr>
                          <th>Name</th>
                          <th>Dose</th>
                          <th>Notes</th>
                        </tr>
                    </thead>
                    <tbody id="myTable">
                        <tr>
                          <td>Buprenorphine</td>
                          <td>5 to 10 mg/day topical</td>
                          <td>AKA Norspan, change weekly</td>
                        </tr>
                        <tr>
                          <td>Celecoxib</td>
                          <td>200 mg PO BD</td>
                          <td>AKA Celebrex, Dose reduce by 50% in liver dysfunction</td>
                        </tr>
                        <tr>
                          <td>Fentanyl</td>
                          <td>12 or 25 mcg/h patch changed every 3 days</td>
                          <td>AKA Actiq</td>
                        </tr>
                        <tr>
                          <td>Ibuprofen</td>
                          <td>400mg PO TDS</td>
                          <td>Avoid in people at risk of GI bleed/renal insult</td>
                        </tr>
                        <tr>
                          <td>Ketorolac</td>
                          <td>50-100mg IM stat</td>
                          <td>Rarely written up regularly. Particularly good for musculoskeletal pain</td>
                        </tr>
                        <tr>
                          <td>Meloxicam</td>
                          <td>7.5 mg PO daily</td>
                          <td>AKA Mobic, Avoid in the elderly, renal impairment and/or a history of gastrointestinal bleeding</td>
                        </tr>
                        <tr>
                          <td>Morphine</td>
                          <td>2.5–5 mg subcut or IV Q2H</td>
                          <td>Can be unlimited in palliative setting</td>
                        </tr>
                        <tr>
                          <td>Oxycodone IR</td>
                          <td>5–10 mg PO Q4H (max 40 mg)</td>
                          <td>AKA Endone, less for the elderly, can constipate</td>
                        </tr>
                        <tr>
                          <td>Targin</td>
                          <td>5/2.5 mg PO BD or <br/>10/5 mg PO BD or <br/> 20/10 mg PO BD</td>
                          <td>Oxycodone+Naloxone, most start on 10/5 (or for under 50 kg, 5/2.5). Up or down titrate depending on breakthrough requirements </td>
                        </tr>
                        <tr>
                          <td>Paracetamol</td>
                          <td>1 g PO Q4H (or QID)</td>
                          <td>AKA Panadol/Tylenol Reduce to 3 g/day or less in severe liver dysfunction</td>
                        </tr>
                        <tr>
                          <td>Tramadol SR </td>
                          <td>100 mg PO TDS</td>
                          <td>aka Tramal, Usually started at lower doses (e.g. BD) and up-titrated if necessary</td>
                        </tr>
                        <tr>
                          <td>Acyclovir</td>
                          <td>200 mg PO 5 times daily (minor viral infection) <br/> 400–800 mg PO 5 times daily (shingles) <br/> 10–15 mg/kg IV Q8H (HSV encephalitis)</td>
                          <td>AKA Zovirax, Also available topically for cold sores!</td>
                        </tr>
                        <tr>
                          <td>Amoxicillin</td>
                          <td>500 mg PO TDS</td>
                          <td>AKA Amoxil</td>
                        </tr>
                        <tr>
                          <td>Amoxicillin with clavulanic acid </td>
                          <td>875/125 mg PO BD</td>
                          <td>AKA Augmentin Duo Forte, usual course is 5 days only</td>
                        </tr>
                        <tr>
                          <td>Ampicillin</td>
                          <td>1 g IV QID</td>
                          <td>AKA Ampicyn</td>
                        </tr>
                        <tr>
                          <td>Azithromycin </td>
                          <td>500 mg IV (or PO) daily</td>
                          <td>AKA Zithromax</td>
                        </tr>
                        <tr>
                          <td>Benzylpenicillin</td>
                          <td>1.2 g IV QID (usual dose) <br/> 2.4 g IV QID (meningitis or IE dose)</td>
                          <td></td>
                        </tr>
                        <tr>
                          <td>Cefaclor</td>
                          <td>500 mg PO TDS</td>
                          <td>AKA Keflor, Good respiratory cover</td>
                        </tr>
                        <tr>
                          <td>Cefazolin</td>
                          <td>500 mg IV TDS <br/> 1 g IV TDS (severe infections) <br/> 2 g IV TDS (endocarditis dose)</td>
                          <td>Favoured by orthopods. Can be used up to QID, has been tolerated up to 12 g/day</td>
                        </tr>
                        <tr>
                          <td>Ceftazidime</td>
                          <td>1–2 g IV TDS</td>
                          <td>Usually stepped down to ciprofloxacin</td>
                        </tr>
                        <tr>
                          <td>Ceftriaxone</td>
                          <td>1 g IV daily</td>
                          <td>Does not cover LAME – Listeria, atypicals, Mycobacteria and Enterococcus. Usually stepped down to cephalexin</td>
                        </tr>
                        <tr>
                          <td>Cephalexin</td>
                          <td>500 mg PO QID</td>
                          <td>AKA Keflex, If compliance due to time is an issue (e.g. busy people), 1 g BD is an acceptable alternative</td>
                        </tr>
                        <tr>
                          <td>Chloramphenicol</td>
                          <td>1–2 cm topical affected eye BD or <br/>2 drops topical each affected eye BD</td>
                          <td>Comes in ointment or drops. The usual course is 5–7 days</td>
                        </tr>
                        <tr>
                          <td>Ciprofloxacin</td>
                          <td>500 mg PO BD (usual dose) <br/>750 mg PO BD (severe infection)</td>
                          <td>Restricted access in Australia – must call PBS for authority. IV mixture also available</td>
                        </tr>
                        <tr>
                          <td>Clindamycin</td>
                          <td>150-300mg PO QID</td>
                          <td>AKA Cleocin</td>
                        </tr>
                        <tr>
                          <td>Doxycycline</td>
                          <td>100 mg PO BD (treatment dose) <br/> 50 mg PO daily (prophylactic dose) <br/> 100 mg PO D (malaria prophylaxis)</td>
                          <td>Don’t lie down afterwards causes painful oesophageal erosion</td>
                        </tr>
                        <tr>
                          <td>Erythromycin</td>
                          <td>400 mg PO QID</td>
                          <td>Can also be used as a GI pro-kinetic</td>
                        </tr>
                        <tr>
                          <td>Famciclovir</td>
                          <td>250–500 mg PO TDS</td>
                          <td>AKA Ezovir or Famvir, must be renally adjusted when eGFR under 30</td>
                        </tr>
                        <tr>
                          <td>Flucloxacillin</td>
                          <td>1–2 g IV QID (acute) <br/> 500 mg–1 g PO QID (step-down, or less severe infections)</td>
                          <td>Standard for most skin-related infections. Beware liver dysfunction</td>
                        </tr>
                        <tr>
                          <td>Fluconazole</td>
                          <td>200 mg PO daily (prophylaxis) <br/>400 mg PO daily (systemic fungal infection)</td>
                          <td>Beware liver dysfunction</td>
                        </tr>
                        <tr>
                          <td>Gentamicin</td>
                          <td>4–6 mg/kg IV daily</td>
                          <td>AKA Gent, Gentamicin levels should be done after the third dose, and then after every subsequent dose. Should not be given indefinitely due to risk of nephro- and ototoxicity</td>
                        </tr>
                        <tr>
                          <td>Meropenem</td>
                          <td>1 g IV TDS</td>
                          <td></td>
                        </tr>
                        <tr>
                          <td>Metronidazole</td>
                          <td>500 mg PO TDS (C. difficile) <br/>400 mg IV BD (triple anti’s)</td>
                          <td>AKA Flagyl or Metro, More effective orally for C. difficile infections</td>
                        </tr>
                        <tr>
                          <td>Moxifloxacin</td>
                          <td>400 mg PO or IV daily</td>
                          <td>Used commonly in pneumonia with penicillin allergies. Often requires approval from antibiotic stewardship</td>
                        </tr>
                        <tr>
                          <td>Tazocin</td>
                          <td>4.5 g IV TDS</td>
                          <td>Piperacillin + Tazobactam, QID in febrile neutropenia</td>
                        </tr>
                        <tr>
                          <td>Trimethoprim</td>
                          <td>300 mg PO nocte</td>
                          <td>Given nocte as it stays in the bladder longer overnight. Avoid in pregnancy</td>
                        </tr>
                        <tr>
                          <td>Bactrim DS</td>
                          <td>800/160 mg PO daily (prophylaxis) <br/> 1.6 g/320 mg PO BD (treatment dose) <br/> 800/160 mg PO BD twice weekly (respiratory prophylaxis)</td>
                          <td>Trimethoprim + Sulfamethoxazole aka Resprim Forte <br/> Patients will usually know how they take their Bactrim, it is important to clarify due to the many different regimens. Can be myelosuppressive</td>
                        </tr>
                        <tr>
                          <td>Valacyclovir</td>
                          <td>400 mg PO daily (prophylaxis)</td>
                          <td>Can be escalated to BD or even TDS for treatment of minor viral infections in the immunocompromised</td>
                        </tr>
                        <tr>
                          <td>Vancomycin</td>
                          <td>1.5 g IV TDS</td>
                          <td>Vancomycin levels should be performed after the third dose, usually every second day (more frequently in the setting of renal impairment)</td>
                        </tr>
                        <tr>
                          <td>Coloxyl + Senna</td>
                          <td>100/16 mg (2 tabs) PO BD</td>
                          <td>Sometimes just given as a single nocte dose depending on requirements. Docusate (coloxyl) can be prescribed without senna at the same dose <br/>Coloxyl = softener, senna = stimulant</td>
                        </tr>
                        <tr>
                          <td>Fleet Enema</td>
                          <td>1–2 enemas PR daily PRN</td>
                          <td>Avoid multiple enemas in a 24-h period if possible <br/> Avoid in AKI/CKD due to phosphate content</td>
                        </tr>
                        <tr>
                          <td>Lactulose</td>
                          <td>20 mL PO BD (constipation) <br/> 30 mL PO up to Q1H (hepatic encephalopathy)</td>
                          <td>Down-titrate the Lactulose in hepatic encephalopathy once patient begins to open their bowels and their conscious state improves</td>
                        </tr>
                        <tr>
                          <td>Microlax enema</td>
                          <td>1 sachet PO daily <br/> 1–2 sachets PO Q10H PRN</td>
                          <td></td>
                        </tr>
                        <tr>
                          <td>PicoPrep</td>
                          <td>2 PO usually at 1600 and 1800 day prior to endoscopy, with a third PRN at 0600 day of scope</td>
                          <td>Safe to use in renal patients</td>
                        </tr>
                        <tr>
                          <td>Cyclizine</td>
                          <td>50 mg PO or <br/> IV Q8H PRN</td>
                          <td>Good for post-op nausea</td>
                        </tr>
                        <tr>
                          <td>Domperidone </td>
                          <td>10 mg PO TDS or <br/>QID pre-meals</td>
                          <td>AKA Motilium, Alternative to metoclopramide for intractable nausea and vomiting, diabetic gastroparesis</td>
                        </tr>
                        <tr>
                          <td>Metoclopramide </td>
                          <td>10 mg PO/IV/IM Q8H PRN (up to maximum of 80 mg in palliative)</td>
                          <td>aka Maxolon <br/>Monitor for dystonic reactions <br/> Contraindicated in bowel obstruction, Parkinson’s disease</td>
                        </tr>
                        <tr>
                          <td>Odansetron</td>
                          <td>4–8 mg PO/SL/IV Q8H PRN</td>
                          <td>aka Zofran, Can be constipating</td>
                        </tr>
                        <tr>
                          <td>Prochlorperazine</td>
                          <td>5–10 mg PO Q8H or Q6H PRN <br/> 12.5 mg IV/IM Q8H or Q6H</td>
                          <td>AKA Stemetil <br/>Central dopaminergic effects, nausea with migraines or vertigo</td>
                        </tr>
                        <tr>
                          <td>Adenosine</td>
                          <td>6 mg rapid IV <br/> then 12 mg after 1–2 min <br/>then 18 mg after another 1–2 min</td>
                          <td>Used for SVT</td>
                        </tr>
                        <tr>
                          <td>Adrenaline</td>
                          <td>1 mg rapid IV (ALS)<br/> 0.5mg IM stat anaphylaxis</td>
                          <td> Cardiac arrest and anaphylaxis</td>
                        </tr>
                        <tr>
                          <td>Amiodarone (ALS)</td>
                          <td>300 mg IV stat (ALS) <br/> 150-300m mg in 100mL 5% dextrose IV over 30-60 min (loading dose in AF or A. flutter) <br/> then 900-1200 mg in 500 mL dextrose over 24/12 (maintenance)</td>
                          <td>Cardiac arrest and AF and A Flutter</td>
                        </tr>
                        <tr>
                          <td>Atropine</td>
                          <td>0.4 - 1mg IV every 5 min (max 2 mg)</td>
                          <td>Bradyarrhythmias, anticholinesterase overdose (with pralidoxime)</td>
                        </tr>
                        <tr>
                          <td>Calcium Chloride 10%</td>
                          <td>10 mL rapid IV every 3 to 5 min</td>
                          <td>Hyperkalemia, stabilises cardiac membrane</td>
                        </tr>
                        <tr>
                          <td>Lignocaine</td>
                          <td>100 mg rapid IV every 3 to 5 min</td>
                          <td>Can be used in cardiac arrest</td>
                        </tr>
                        <tr>
                          <td>Noradrenaline</td>
                          <td>2 mg in 500 mL NaCl 0.9% IV infusion at 1 5 mL/h</td>
                          <td>Vasopressor</td>
                        </tr>
                        <tr>
                          <td>Amiodarone oral</td>
                          <td>100 mg PO mane (maintenance) <br/> 300–400 mg PO stat (loading dose)</td>
                          <td>aka codarone, monitor thyroid function</td>
                        </tr>
                        <tr>
                          <td>Amlodipine</td>
                          <td>5 mg PO daily</td>
                          <td>AKA Norvasc</td>
                        </tr>
                        <tr>
                          <td>Aspirin</td>
                          <td>100 mg PO mane <br/> 300 mg PO stat (ACS)</td>
                          <td>aka Astrix or Cartia</td>
                        </tr>
                        <tr>
                          <td>Atenolol</td>
                          <td>25–50 mg PO daily</td>
                          <td>aka Noten</td>
                        </tr>
                        <tr>
                          <td>Atorvastatin</td>
                          <td>40 mg PO daily (standard) <br/> 20 mg PO daily (liver reduced) <br/> 80 mg PO daily (post-ACS)</td>
                          <td>might consider dose reduce in liver dysfunction</td>
                        </tr>
                        <tr>
                          <td>Bisoprolol</td>
                          <td>2.5–10 mg PO daily <br/> std starting dose is 5mg PO daily</td>
                          <td>aka Bicor</td>
                        </tr>
                        <tr>
                          <td>Carvedilol</td>
                          <td>6.25 mg PO daily</td>
                          <td>aka Dicarz</td>
                        </tr>
                        <tr>
                          <td>Clopidogrel</td>
                          <td>75 mg PO mane <br/> 600 mg PO (ACS)</td>
                          <td>CoPlavix = 75mg CLopidogrel + 100mg Aspirin <br/> use restricted on PBS to post-ACS, stroke, or cardiac stent</td>
                        </tr>
                        <tr>
                          <td>Digoxin</td>
                          <td>62.5 mcg PO mane <br/> 500 mcg PO stat with 250 mcg 6 hours later <br/> 250 mcg another 6 h later (loading dose)</td>
                          <td>serum levelscan be done to ensure within therapeutic window</td>
                        </tr>
                        <tr>
                          <td>Diltiazem SR</td>
                          <td>180 mg PO daily</td>
                          <td>aka Cardizem, increase by 60mg as required</td>
                        </tr>
                        <tr>
                          <td>Frusemide</td>
                          <td>40 mg PO mane (start) <br/> 40 mg PO BD (active diuresis)</td>
                          <td>aka lasix and uremide, increase by 40mg as required</td>
                        </tr>
                        <tr>
                          <td>GTN</td>
                          <td>Anginine 300 to 600 microg PO PRN <br/>Nitrolingual spray 400 microg sublingual PRN</td>
                          <td>1 Anginine is 600 microg</td>
                        </tr>
                        <tr>
                          <td>Indapamide</td>
                          <td>1.5 - 2.5 mg PO daily</td>
                          <td>aka Natrilix</td>
                        </tr>
                        <tr>
                          <td>Ibesartan</td>
                          <td>150 mg PO daily</td>
                          <td>aka Avapro</td>
                        </tr>
                        <tr>
                          <td>Isosorbide mononitrate SR</td>
                          <td>30 - 60 mg PO mane</td>
                          <td>small vessel ischaemia aka ISNM, Imdur</td>
                        </tr>
                        <tr>
                          <td>Metoprolol</td>
                          <td>25mg PO BD</td>
                          <td>AKA Minax, up to 100mg PO BD</td>
                        </tr>
                        <tr>
                          <td>Metoprolol XR</td>
                          <td>47.5 – 90 mg PO daily</td>
                          <td>aka Toprol</td>
                        </tr>
                        <tr>
                          <td>Nebivolol</td>
                          <td>1.25 – 10 mg PO daily</td>
                          <td>aka Nebilet</td>
                        </tr>
                        <tr>
                          <td>Nicorandil </td>
                          <td>10 mg PO daily</td>
                          <td>aka Ikorel</td>
                        </tr>
                        <tr>
                          <td>Olemsartan</td>
                          <td>20–40 mg PO daily</td>
                          <td>aka Olmetec</td>
                        </tr>
                        <tr>
                          <td>Perindopril</td>
                          <td>2.5 – 10 mg PO daily</td>
                          <td>aka Coversyl</td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>
                        <tr>
                          <td></td>
                          <td></td>
                          <td></td>
                        </tr>



                    </tbody>
                </table>
            </div>

            </div>

        </main>
    </body>
</html>
